---
input_text: 'Liver Expression of a MiniATP7B Gene Results in Long-Term Restoration
  of Copper Homeostasis in a Wilson Disease Model in Mice.Gene therapy with an adeno-associated
  vector (AAV) serotype 8 encoding the human ATPase copper-transporting beta polypeptide
  (ATP7B) complementary DNA (cDNA; AAV8-ATP7B) is able to provide long-term copper
  metabolism correction in 6-week-old male Wilson disease (WD) mice. However, the
  size of the genome (5.2 kilobases [kb]) surpasses the optimal packaging capacity
  of the vector, which resulted in low-yield production; in addition, further analyses
  in WD female mice and in animals with a more advanced disease revealed reduced therapeutic
  efficacy, as compared to younger males. To improve efficacy of the treatment, an
  optimized shorter AAV vector was generated, in which four out of six metal-binding
  domains (MBDs) were deleted from the ATP7B coding sequence, giving rise to the miniATP7B
  protein (Delta57-486-ATP7B). In contrast to AAV8-ATP7B, AAV8-miniATP7B could be
  produced at high titers and was able to restore copper homeostasis in 6- and 12-week-old
  male and female WD mice. In addition, a recently developed synthetic AAV vector,
  AAVAnc80, carrying the miniATP7B gene was similarly effective at preventing liver
  damage, restoring copper homeostasis, and improving survival 1 year after treatment.
  Transduction of approximately 20% of hepatocytes was sufficient to normalize copper
  homeostasis, suggesting that corrected hepatocytes are acting as a sink to eliminate
  excess of copper. Importantly, administration of AAVAnc80-miniATP7B was safe in
  healthy mice and did not result in copper deficiency. Conclusion: In summary, gene
  therapy using an optimized therapeutic cassette in different AAV systems provides
  long-term correction of copper metabolism regardless of sex or stage of disease
  in a clinically relevant WD mouse model. These results pave the way for the implementation
  of gene therapy in WD patients.'
raw_completion_output: |-
  primary_disease: Wilson Disease (WD)

  medical_actions: Gene therapy with adeno-associated vector (AAV) serotype 8 encoding ATP7B; Generation of an optimized shorter AAV vector; Administration of AAVAnc80-miniATP7B

  symptoms: Liver damage; Disrupted copper homeostasis

  chemicals: ATP7B; miniATP7B; AAV8-ATP7B; AAV8-miniATP7B; AAVAnc80-miniATP7B

  action_annotation_relationships: Gene therapy with adeno-associated vector (AAV) serotype 8 encoding ATP7B TREATS disrupted copper homeostasis IN Wilson Disease (WD); Generation of an optimized shorter AAV vector TREATS disrupted copper homeostasis IN Wilson Disease (WD); Administration of AAVAnc80-miniATP7B PREVENTS liver damage IN Wilson Disease (WD); Administration of AAVAnc80-miniATP7B TREATS disrupted copper homeostasis IN Wilson Disease (WD)
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Administration of AAVAnc80-miniATP7B TREATS disrupted copper homeostasis IN Wilson Disease (WD)

  ===

extracted_object:
  primary_disease: MONDO:0010200
  medical_actions:
    - Gene therapy with adeno-associated vector (AAV) serotype 8 encoding ATP7B
    - Generation of an optimized shorter AAV vector
    - Administration of AAVAnc80-miniATP7B
  symptoms:
    - Liver damage
    - Disrupted copper homeostasis
  chemicals:
    - ATP7B
    - miniATP7B
    - AAV8-ATP7B
    - AAV8-miniATP7B
    - AAVAnc80-miniATP7B
  action_annotation_relationships:
    - subject: <Gene therapy>
      predicate: <TREATS>
      object: <disrupted copper homeostasis>
      qualifier: MONDO:0010200
      subject_qualifier: <>
      object_qualifier: <>
      subject_extension: <adeno-associated vector (AAV) serotype 8 encoding ATP7B>
      object_extension: <disrupted copper homeostasis>
    - subject: Generation of an optimized shorter AAV vector
      predicate: TREATS
      object: disrupted copper homeostasis
      qualifier: MONDO:0010200
      subject_qualifier: optimized shorter
      subject_extension: AAV vector
    - subject: Administration
      predicate: PREVENTS
      object: liver damage
      qualifier: MONDO:0010200
      subject_extension: AAVAnc80-miniATP7B
    - subject: Administration
      predicate: TREATS
      object: disrupted copper homeostasis
      qualifier: MONDO:0010200
      subject_extension: AAVAnc80-miniATP7B
named_entities:
  - id: MONDO:0010200
    label: Wilson's disease
  - id: HP:0001695
    label: cardiac arrest
  - id: HP:0001685
    label: myocardial fibrosis
  - id: HP:0001663
    label: ventricular fibrillation
  - id: CHEBI:38161
    label: Chelating agents
  - id: MAXO:0000016
    label: Cell therapy
  - id: MAXO:0001001
    label: Gene therapy
  - id: HP:0001392
    label: Hepatic disease
  - id: CHEBI:30703
    label: Tetrathiomolybdate (TTM)
  - id: CHEBI:28694
    label: Copper (Cu)
  - id: CHEBI:18248
    label: Iron (Fe)
  - id: CHEBI:27363
    label: Zinc (Zn)
  - id: CHEBI:82594
    label: Ferritin (SFr)
  - id: HP:0001744
    label: Splenomegaly
  - id: HP:0001541
    label: Ascites
  - id: HP:0001394
    label: Cirrhosis
  - id: CHEBI:46195
    label: Paracetamol
  - id: HP:0006554
    label: Acute Liver Failure
  - id: CHEBI:21547
    label: N-acetyl aspartate (NAA)
  - id: CHEBI:15354
    label: Choline (Cho)
  - id: CHEBI:157802
    label: Creatine (Cr)
  - id: MAXO:0009095
    label: Treatment with zinc
  - id: HP:0001399
    label: Liver failure
  - id: CHEBI:7959
    label: d-penicillamine
  - id: CHEBI:39501
    label: Trientine
  - id: MAXO:0001175
    label: liver transplantation
  - id: MAXO:0000376
    label: liver biopsy
  - id: HP:0033771
    label: pleuritic chest pain
  - id: HP:0000952
    label: jaundice
  - id: HP:0001919
    label: acute kidney injury
  - id: MAXO:0035080
    label: apoptosis assays
  - id: CHEBI:33709
    label: amino acids
  - id: MONDO:0013792
    label: Intracerebral Hemorrhage
  - id: HP:0001342
    label: Intracerebral hemorrhage
  - id: MONDO:0014789
    label: CCDC115-CDG
  - id: HP:0003124
    label: hypercholesterolemia
  - id: HP:0003155
    label: elevated alkaline phosphatases
  - id: MAXO:0000533
    label: Molecular genetic testing
  - id: MAXO:0001181
    label: Serum alkaline phosphatase measurement
  - id: HP:0032199
    label: Abnormal prothrombin time
  - id: HP:0200032
    label: Kayser-Fleischer rings
  - id: CHEBI:50868
    label: Penicillamine
  - id: HP:0001878
    label: hemolytic anemia
  - id: MAXO:0010203
    label: echocardiography
  - id: HP:0005135
    label: T wave abnormality
  - id: HP:0011703
    label: sinus tachycardia
  - id: HP:0001688
    label: sinus bradycardia
  - id: HP:0006682
    label: premature ventricular contraction
  - id: CHEBI:35623
    label: antiepileptics
  - id: HP:0001410
    label: Hepatic dysfunction
  - id: CHEBI:62984
    label: Zinc acetate
  - id: MONDO:0018874
    label: Acute Myeloid Leukemia (AML)
  - id: HP:0001873
    label: Thrombocytopenia
  - id: CHEBI:41977
    label: Daunorubicin
  - id: CHEBI:28680
    label: Cytarabine
  - id: HP:0004808
    label: Acute Myeloid Leukemia
  - id: HP:0001336
    label: Myoclonus
  - id: HP:0001250
    label: Epileptic seizures
  - id: HP:0001298
    label: Encephalopathy
  - id: HP:0001337
    label: Tremor
  - id: HP:0002315
    label: Headache
  - id: CHEBI:6437
    label: Levetiracetam
  - id: HP:0002480
    label: hepatic encephalopathy
  - id: HP:0001882
    label: leukopenia
  - id: MONDO:0007329
    label: Indian childhood cirrhosis
  - id: HP:0001945
    label: fever
  - id: HP:0002908
    label: direct hyperbilirubinemia
  - id: HP:0002910
    label: elevated transaminases
  - id: HP:0001903
    label: anemia
  - id: HP:0001409
    label: portal hypertension
  - id: MONDO:0004789
    label: Cholangitis
  - id: MAXO:0000127
    label: Genetic analysis
  - id: MONDO:0007256
    label: Hepatocellular carcinoma (HCC)
  - id: CHEBI:26708
    label: NA
  - id: HP:0001402
    label: Hepatocellular carcinoma (HCC)
  - id: MAXO:0001298
    label: therapy
  - id: MONDO:0019542
    label: Acute Liver Failure
  - id: HP:0002359
    label: Frequent Falls
  - id: MONDO:0015143
    label: Rare movement disorders
  - id: HP:0100022
    label: Movement disorders
  - id: HP:0033329
    label: Abnormal postural reflex
  - id: MONDO:0002492
    label: acute kidney injury
  - id: MAXO:0000973
    label: slit-lamp examination
  - id: HP:0033429
    label: Neuroinflammation
  - id: CHEBI:18291
    label: manganese
  - id: CHEBI:28938
    label: ammonia
  - id: HP:0001433
    label: hepatosplenomegaly
  - id: HP:0002904
    label: hyperbilirubinemia
  - id: HP:0003256
    label: coagulopathy
  - id: MONDO:0012105
    label: ANCA-associated Vasculitis
  - id: HP:0002105
    label: Hemoptysis
  - id: HP:0002094
    label: Dyspnea
  - id: HP:0002907
    label: Microscopic hematuria
  - id: HP:0000093
    label: Proteinuria
  - id: CHEBI:24261
    label: Glucocorticoid
  - id: CHEBI:4027
    label: Cyclophosphamide
  - id: CHEBI:8764
    label: Mycophenolate mofetil
  - id: HP:0040223
    label: pulmonary hemorrhage
  - id: HP:0000790
    label: hematuria
  - id: MONDO:0100193
    label: End-stage liver diseases
  - id: HP:0002040
    label: Esophageal varices
  - id: HP:0100626
    label: End-stage liver diseases
  - id: MONDO:0017014
    label: children
  - id: HP:0200123
    label: chronic hepatitis
  - id: HP:0001397
    label: steatosis
  - id: CHEBI:28787
    label: targeted next-generation sequencing (NGS)
  - id: MAXO:0000527
    label: Physical examination
  - id: MAXO:0010200
    label: Abdominal ultrasonography (Abdl Ur)
  - id: HP:0010837
    label: Decreased serum ceruloplasmin
  - id: CHEBI:37708
    label: Alanine transaminase (ALT)
  - id: CHEBI:76649
    label: Aspartate transaminase (AST)
  - id: HP:0200120
    label: chronic active hepatitis
  - id: HP:0002896
    label: liver cancer
  - id: HP:0002354
    label: memory dysfunction
  - id: HP:0100543
    label: cognitive impairment
  - id: CHEBI:23414
    label: CuSO4
  - id: CHEBI:16856
    label: glutathione (GSH)
  - id: CHEBI:566274
    label: malondialdehyde (MDA)
  - id: CHEBI:31882
    label: N-methyl-D-aspartate
  - id: HP:0002885
    label: Mallory-Denk body (MDB) formation
  - id: CHEBI:16990
    label: Bilirubin
